Melatonin and Gemtesa drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Melatonin (melatonin) and Gemtesa (vibegron). Common drug interactions include formication among females and rash among males.
The phase IV clinical study analyzes what interactions people have when they take Melatonin and Gemtesa. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.
What is Melatonin?
Melatonin has active ingredients of melatonin. It is often used in insomnia. eHealthMe is studying from 56,212 Melatonin users. Check the latest studies of Melatonin.
What is Gemtesa?
Gemtesa has active ingredients of vibegron. eHealthMe is studying from 2,648 Gemtesa users. Check the latest studies of Gemtesa.
34 people who take Melatonin and Gemtesa together, and have interactions are studied.

What are the common drug interactions of Melatonin and Gemtesa, by gender? *:
female:
- Formication (a sensation that exactly resembles that of small insects crawling on (or under) the skin)
- Hallucination (an experience involving the perception of something not present)
- Hallucinations, mixed (sensations that appear real but are created by your mind -mixed)
- Hypersensitivity
- Hypersomnia (excessive daytime sleepiness (eds))
- Incontinence (lack of moderation or self-control)
- Intervertebral disc protrusion (spinal disc protrusion)
- Lacrimation increased
- Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
- Psychomotor hyperactivity (feelings of extreme restlessness)
male:
- Rash
- Dizziness
- Injection site pain
- Injection site pruritus (severe itching at injection site)
- Injection site reaction
- Injection site swelling
- Joint injury
- Memory impairment
- Nasopharyngitis (inflammation of the nasopharynx)
- Peripheral swelling
What are the common drug interactions of Melatonin and Gemtesa, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Restlessness (not able to rest)
30-39:
n/a
40-49:
- Acne (skin problems that cause pimples)
- Scab (a hard coating on the skin formed during the wound healing)
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
- Drug ineffective
- Dry mouth
- Formication (a sensation that exactly resembles that of small insects crawling on (or under) the skin)
- Hypersensitivity
- Lacrimation increased
- Rash
- Rash pruritic (redness with itching)
50-59:
- Arthralgia (joint pain)
- Contusion (a type of hematoma of tissue in which capillaries)
- Drug hypersensitivity
- Eye pain
- Hypersomnia (excessive daytime sleepiness (eds))
- Sinusitis (inflammation of sinus)
60+:
- Headache (pain in head)
- Dyspnoea (difficult or laboured respiration)
- Dyspepsia (indigestion)
- Fatigue (feeling of tiredness)
- Heart rate decreased
- Heart rate irregular
- Inguinal hernia (hernia in which a loop of intestine enters the inguinal canal; the most common type of hernia in males)
- Injection site discharge
- Injection site erythema (redness at injection site)
- Injection site pain
What are the existing conditions these people have? *
- Immunodeficiency Common Variable: 7 people, 20.59%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 4 people, 11.76%
- Parkinson's Disease: 4 people, 11.76%
- Osteoporosis (bones weak and more likely to break): 4 people, 11.76%
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy (long lasting infection of nerves outside brain and spinal cord): 4 people, 11.76%
- Neurotrophic Keratopathy (decreased corneal sensitivity and poor corneal healing): 3 people, 8.82%
- Urticaria (rash of round, red welts on the skin that itch intensely): 2 people, 5.88%
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 5.88%
- Incontinence (lack of moderation or self-control): 2 people, 5.88%
- Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 2 people, 5.88%
* Approximation only. Some reports may have incomplete information.
Do you take Melatonin and Gemtesa?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Melatonin and Gemtesa:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Melatonin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Gemtesa:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Melatonin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Gemtesa and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on melatonin and vibegron (the active ingredients of Melatonin and Gemtesa, respectively), and Melatonin and Gemtesa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Augmentin '125' and Adriamycin Pfs - 3 seconds ago
- Revia vs. Alcohol, side effect and effectiveness comparison - 17 seconds ago
- Drug interactions of Zetia and Zolpidem - 32 seconds ago
- Drug interactions of Ibrance and Tacrolimus - 2 minutes ago
- Could Lopressor cause Muscle Atrophy? - 2 minutes ago
- Could Lupron Depot cause Nausea? - 2 minutes ago
- Prinivil vs. Vitamin D, side effect and effectiveness comparison - 2 minutes ago
- Drug interactions of Cephalexin and Nuplazid - 2 minutes ago
- Could Xeloda cause Protein Urine Present? - 2 minutes ago
- Could Depakene cause Musculoskeletal Pain? - 3 minutes ago